NCT07537569 Preoperative Oncogeriatric Assessment in Patients Undergoing Hepatectomy
| NCT ID | NCT07537569 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| Condition | Hepatic Malignancies |
| Study Type | INTERVENTIONAL |
| Enrollment | 242 participants |
| Start Date | 2026-04-09 |
| Primary Completion | 2029-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 242 participants in total. It began in 2026-04-09 with a primary completion date of 2029-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to bridge the gap between geriatric medicine and surgical oncology. The findings will provide valuable insights into optimizing perioperative care for older adults, enhancing surgical safety, and improving long-term recovery trajectories, thereby supporting a more patient-centered, multidisciplinary approach in the management of elderly patients undergoing hepatectomy
Eligibility Criteria
Inclusion Criteria: * Patients aged ≥ 70 years * Diagnosed hepatic malignancies requiring hepatectomy * Eligible for curative surgery as determined by multidisciplinary team * Ability to provide informed consent. Exclusion Criteria: * Ineligibility for surgery due to advanced disease or severe comorbidities * Severe cognitive impairment (MMSE score \< 18) * Refusal to participate
Contact & Investigator
Felice Giuliante, MD
PRINCIPAL INVESTIGATOR
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Frequently Asked Questions
Who can join the NCT07537569 clinical trial?
This trial is open to participants of all sexes, aged 70 Years or older, studying Hepatic Malignancies. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07537569 currently recruiting?
Yes, NCT07537569 is actively recruiting participants. Contact the research team at chiara.schipa@policlinicogemelli.it for enrollment information.
Where is the NCT07537569 trial being conducted?
This trial is being conducted at Roma, Italy.
Who is sponsoring the NCT07537569 clinical trial?
NCT07537569 is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The principal investigator is Felice Giuliante, MD at Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The trial plans to enroll 242 participants.